MAPK3 and head and neck squamous cell carcinoma: To determine whether Erk1/2 phosphorylation plays a role in HNSCC cells’ susceptibility to erastin, we evaluated the cell viabilities in response to ravoxertinib, erastin, and their combination (Figure 6a,b).